Jpmorgan Chase & CO Accelerate Diagnostics, Inc Transaction History

Jpmorgan Chase & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.46 - $0.77 $670,429 - $1.12 Million	-1,457,455 Reduced 100.0%	17 $0
Q4 2022 Feb 13, 2023	BUY	$0.51 - $17.1 $4,513 - $151,335	8,850 Added 0.61%	1,457,472 $1.03 Million
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $1.08 Million - $18.2 Million	1,069,284 Added 281.88%	1,448,622 $2.2 Million
Q2 2022 Aug 11, 2022	SELL	$0.54 - $1.41 $21,071 - $55,019	-39,021 Reduced 9.33%	379,338 $377,000
Q1 2022 May 11, 2022	BUY	$1.4 - $5.15 $88,918 - $327,091	63,513 Added 17.9%	418,359 $602,000
Q4 2021 Feb 10, 2022	BUY	$4.27 - $6.97 $1.46 Million - $2.38 Million	341,743 Added 2608.13%	354,846 $1.85 Million
Q3 2021 Nov 12, 2021	BUY	$5.31 - $8.25 $69,576 - $108,099	13,103 New	13,103 $76,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $115M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.